PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

Docetaxel palmitate liposomes

Inquiry

Cat. No.: X26-05-ZQ916

Docetaxel palmitate liposomes

Name: Docetaxel palmitate liposomes
SKU: X26-05-ZQ916

Inquiry

Synonym: Docetaxel palmitate LPs; DTX palmitate liposomes; DTX palmitate LPs; Docetaxel palmitate-loaded liposomes

Product Size

100 mg; 250 mg; 500 mg; 1 g; 5 g

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

This formulation features docetaxel palmitate liposomes (DTA-LPs) utilizing a lipophilic prodrug strategy for enhanced structural stability. The core matrix incorporates the hydrophobic prodrug docetaxel palmitate directly into the hydrocarbon domain of the lipid bilayer. This chemical modification increases the affinity of the active molecule for the lipid phase and prevents its premature precipitation out of the membrane. The resulting vesicles exhibit a highly uniform spherical morphology and high structural rigidity.

Source

Custom synthesis

Functional Group

Docetaxel palmitate

Form

Solid or powder

Purity

≥95%

Impurities

No visible impurities to the naked eye.

Identity

HPLC/MS/NMR

Publications

Publications (0)

Publications

×

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.